Thrombotic and Hemorrhagic Syndromes Associated with Autoimmunity and Infection

Massimo Franchini; Antonio Coppola; Marcel Levi; Emmanuel J. Favaloro

doi:10.1055/s-0032-1315760

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2012; 38(05): 421-424
DOI: 10.1055/s-0032-1315760

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thrombotic and Hemorrhagic Syndromes Associated with Autoimmunity and Infection

Massimo Franchini

¹Department of Transfusion Medicine and Hematology, “C. Poma” Hospital, Mantova, Italy

,

Antonio Coppola

²Department of Clinical and Experimental Medicine, Regional Reference Center for Coagulation Disorders, Federico II University Hospital, Naples, Italy

,

Marcel Levi

³Department of Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands

,

Emmanuel J. Favaloro

⁴Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, New South Wales, Australia

› Author Affiliations

Abstract

Full Text

References

References
1 Levi M. Disseminated intravascular coagulation: a disease-specific approach. Semin Thromb Hemost 2010; 36 (4) 363-365
2 Favaloro EJ, Wong RCW. The antiphospholipid syndrome: diagnosis, pathogenesis, laboratory testing and management. Semin Thromb Hemost 2012; 38 (4) 209-304
3 Coppola A, Favaloro EJ, Tufano A, Di Minno MND, Cerbone AM, Franchini M. Acquired inhibitors of coagulation factors: part I—acquired hemophilia A. Semin Thromb Hemost 2012; 38 (5) 433-446
4 Franchini M, Lippi G, Favaloro EJ. Acquired inhibitors of coagulation factors: part II. Semin Thromb Hemost 2012; 38 (5) 447-453
5 Stasi R. Immune thrombocytopenia: pathophysiologic and clinical update. Semin Thromb Hemost 2012; 38 (5) 454-462
6 Franchini M, Vescovi PP, Garofano M, Veneri D. Helicobacter pylori-associated thrombocytopenic purpura: a narrative review. Semin Thromb Hemost 2012; 38 (5) 463-468
7 Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost 2011; 37 (6) 621-630
8 Tsai H-M. Autoimmune thrombocytopenic microangiopathy: advances in pathogenesis, diagnosis, and management. Semin Thromb Hemost 2012; 38 (5) 469-482
9 Favaloro EJ. Hemolytic uremic syndrome. Preface. Semin Thromb Hemost 2010; 36 (6) 573-574
10 Zhou Z, Nguyen TC, Guchhait P, Dong JF. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost 2010; 36 (1) 71-81
11 Prechel M, Walenga JM. Heparin-induced thrombocytopenia: an update. Semin Thromb Hemost 2012; 38 (5) 483-496
12 Linkins LA, Warkentin TE. Heparin-induced thrombocytopenia: real-world issues. Semin Thromb Hemost 2011; 37 (6) 653-663
13 Di Minno MND, Iervolino S, Lupoli R , et al. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis. Semin Thromb Hemost 2012; 38 (5) 497-505
14 Levi M, van der Poll T, Schultz M. Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost 2012; 38 (5) 506-514
15 Tufano A, Di Capua M, Coppola A , et al. The infectious burden in atherothrombosis. Semin Thromb Hemost 2012; 38 (5) 515-523
16 Dentali F, Nicolini E, Ageno W. Venous and arterial thrombosis associated with HIV infection. Semin Thromb Hemost 2012; 38 (5) 524-529
17 Squizzato A, Gerdes VEA. Viral hepatitis and thrombosis: a narrative review. Semin Thromb Hemost 2012; 38 (5) 530-534
18 Dentali F, Sironi AP, Ageno W , et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012; 38 (5) 535-548